June 27, 2013 ·
Leave a comment
The Canadian Business Association of North Carolina (CBA-NC) is pleased to announce the addition of five Triangle-area business leaders, Paul Meade, Geoffrey Sinn, Henry Grzes, David Byerley, and Andrea Carska-Sheppard to its board of directors.
CBA-NC is an exchange where leaders meet to share knowledge, connect, network, and build awareness of the significance of the US-Canadian relationship. The association sponsors a distinguished speaker series, focused on cross-border issues and policies of current concern. The organization’s most recent event featured former Quintiles chief Sandy Costa, speaking at the Research Triangle Park manufacturing facility of Medicago, a Quebec-headquartered company manufacturing vaccines from tobacco plants.
The organization holds multiple events throughout the course of the year around the state of North Carolina, providing great opportunities for participants to create new personal and professional relationships while continuing to strengthen business ties with their shared home country of Canada. Many of the executives who participate in CBA-NC events represent firms who continue to do business on both sides of the border.
Another of the organization’s stated goals is to assist in facilitating the successful transition of new companies and individuals arriving from Canada to pursue business in North Carolina, as well as helping North Carolinians meet business objectives in Canada.
The Canadian Business Association of North Carolina’s ... read more »
November 2, 2010 ·
Lisa Smith helped to start Thought Leader Select in 2006 with Paul Meade and Kristen Smithwick. As Executive Vice President of Research and Development, Lisa ensures the company’s highest research standards. She has years of experience leading research and consulting projects for the biopharmaceutical, diagnostic and healthcare industries. Through her work, Lisa has helped scores of companies improve thought leader engagement strategies and strengthen medical affairs, commercial and clinical development functions.
The Thought Leader Select Blog sat down with Lisa, the bedrock of Thought Leader Select’s industry-leading research, to learn more about her role within the company, what drives her at work and the extracurricular passions that make her unique.
TLS Blog: Good morning, Lisa. Why did you help to found Thought Leader Select?
Lisa Smith: I was working at Clear Point Health with Paul Meade on a variety of interesting projects for biopharmaceutical clients. One client, in particular, needed our help to understand how to make advisory boards more effective. Paul and I interviewed executives in several pharmaceutical companies and key opinion leaders to identify best practices in developing, planning and executing effective advisory board meetings. This work sparked our interest in thought leader engagement. Following our work on advisory board best practices, Paul and I helped the same client better engage a group of KOLs by devising an organized system ... read more »
June 9, 2010 ·
Leave a comment
Cammie Brannan joined Clear Point Health and Thought Leader Select as a research associate in 2005. In her current role managing thought leader relations at Thought Leader Select, Cammie works directly with physicians and other health care professionals to ensure the accuracy and integrity of the data for each key opinion leader assessment. Cammie spent a decade working in accounting and financial management, earning a reputation as a leader in compiling data and optimizing its presentation for decision-makers in a variety of industries. Prior to joining Thought Leader Select, Cammie worked for a North Carolina firm that provided research and consulting services to the pharmaceutical industry, with emphasis on the drug-naming process.
The Thought Leader Select Blog sat down with Cammie to discuss her industry experience and her professional contribution to Thought Leader Select.
TLS Blog: Good morning, Cammie. Why did you join Thought Leader Select?
Cammie Brannan: I had been doing contract market research for a company in Raleigh, NC. We specialized in all of the aspects of naming new pharmaceutical products—market research, market testing, etc. I interacted quite a bit with health care professionals—we surveyed them.—gaining their valuable feedback on potential new names for drugs. For instance, were the names appealing, memorable, and would they be confused with other products on the market. It was a pretty interesting business.
While I was ... read more »
June 2, 2010 ·
Leave a comment
Paul Meade, a 25-year veteran of the pharmaceutical industry, founded Thought Leader Select in 2006. Throughout his career, Paul served in several leadership positions in sales, marketing, and strategic planning, culminating in his role of director of worldwide commercial development for predictive medicine at GlaxoSmithKline.
After leaving GSK, Paul launched two companies, Clear Point Health, in 2005, and Thought Leader Select, in 2006. Paul’s work with these two companies entails marketing planning, consulting for research and development and clinical operations, as well as his breakthrough work with medical expert collaborations for the pharmaceutical industry.
The Thought Leader Select Blog sat down with Paul to discuss his industry experience and his professional contribution to Thought Leader Select.
TLS Blog: Good afternoon, Paul. Why did you start Thought Leader Select?
Paul Meade: About a year before starting the company, I had begun consulting with the health industry with my partner, Lisa Smith, through our company, Clear Point Health. We were taking on a number of projects, working with medical affairs teams, marketing teams, and research and development groups within the industry.
One of our large clients came to me and told me that, even though they’d been working with thought leaders for over ten years, they realized how little they really knew about them. When they sat down to consolidate all of their knowledge about their medical ... read more »
May 11, 2010 ·
Leave a comment
May 11, 2010 (CHAPEL HILL, NC) Paul Meade, founder and president of Thought Leader Select, a North Carolina firm dedicated to key opinion leader (KOL) development solutions for the biopharmaceutical industry, received a master of public health degree from the University of North Carolina at Chapel Hill on May 8, 2010.
The Gillings School of Global Public Health at UNC awarded Meade, a 25-year veteran of the pharmaceutical industry, with a master of public health degree and a certificate in public health ethics in the Public Health Leadership Program. Meade’s research report, “How Volunteer Community Organizations Can Assist State Public Health Departments During Pandemic Influenza,” explored specific possibilities for the Civil Air Patrol, a volunteer non-profit national organization and an auxiliary of the United States Air Force, to assist state public health officials during widespread outbreaks of influenza.
The master of public health degree is Meade’s second master’s degree. He earned a master of science in biomedical science from the University of Guelph (Canada) in 1977, following his bachelor of science degree in biology and chemistry from Acadia University (Canada) in 1971.
During his 25-year career in the pharmaceutical industry, Meade served in a variety of leadership positions at Merck and GlaxoSmithKline. During his ten years at Merck, Meade worked his way from a sales representative position to director of marketing planning for ... read more »